Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166400 · ClinicalTrials.gov registry record · Phase 4
A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00166400: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT00166400 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00166400, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
Mitral valve regurgitation (leakage of the mitral valve of the heart) is frequent and currently there is no specific medical therapy. Mitral regurgitation is a slowly progressive disease that frequently requires surgical treatment. This randomized clinical trial will use Metoprolol, a common beta-blocker medication, to determine if medical treatment impacts mitral valve disease progression.
Interventions
- DRUG metoprolol succinate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00166400
The ClinicalTrials.gov registry entry for NCT00166400 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which metoprolol succinate is the first listed.
NCT00166400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00166400 about?
NCT00166400 is a clinical study titled "A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.". Mitral valve regurgitation (leakage of the mitral valve of the heart) is frequent and currently there is no specific medical therapy. Mitral regurgitation is a slowly progressive disease that frequently requires surgical treatment. This randomized clinical trial will use Metoprolol, a common beta-bl...
What is the current status of trial NCT00166400?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2004-07. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00166400?
The interventions under investigation include: metoprolol succinate (DRUG).
Who is sponsoring clinical trial NCT00166400?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.